Company · Healthtech & Bio

Biorce

www.biorce.com ↗ ·Barcelona ·Series A

Biorce is a Barcelona-based healthtech startup that built Aika, an AI operating system for clinical trial development covering protocol design, feasibility analysis, patient identification, budgeting, contracting, monitoring, and regulatory submission. Founded in 2024 by former life-sciences consultants, it serves pharma companies, biotechs, and CROs and claims to cut clinical development costs and timelines by roughly 50-70%. It closed a $52.5M Series A in February 2026 led by DST Global, bringing total funding to over $60M in its first year, and is expanding from Barcelona into Austin and New York.

Founded

2024

Founders

News

Rounds

Investors

SectorsHealthtech, Artificial Intelligence, Clinical Research, Biotech Start-up MapHealthtech & Bio › Clinical software & health data

Profile updated 21 Jul 2026

Founders

Clara Bernardes

Co-Founder & Chief Scientific Officer (Head of Clinical)

Diogo Pisoeiro

Co-Founder & Chief Product Officer

José Faria

Co-Founder & Chief Technology Officer

Pedro Coelho

Founder & CEO

Global models 5

Formation Bio

United States · formation.bio ↗

AI-driven platform automating clinical trial and drug development processes end-to-end, the closest large-scale comparable to Biorce's Aika.

$619MComparable

Reify Health

United States · www.reifyhealth.com ↗

Software platform for clinical trial enrollment, operations, and site management, addressing the same trial-execution bottlenecks as Aika.

$478MComparable

Paradigm

United States · www.paradigmhealth.ai ↗

AI-powered platform embedding clinical trials into routine care, similarly aimed at accelerating trial design and patient access.

$281MComparable

Unlearn.AI

United States · www.unlearn.ai ↗

Uses AI-generated digital twins to speed up clinical trial design and reduce required patient enrollment, a close analog to Aika's protocol automation.

$135MComparable

Deep 6 AI

United States · deep6.ai ↗

AI software matching patients to clinical trials to accelerate feasibility and enrollment, one of the core functions Aika automates.

$77.9MComparable

Investors 6

DST Global Partners

dst-global.com ↗

Investor Russia

Endeavor Catalyst

endeavor.org/catalyst

Investor United States

Mustard Seed Maze

Investor Portugal

Plug and Play Tech Center

plugandplaytechcenter.com

Investor Spain

YZR Capital

yzr-capital.com ↗

Investor Germany

Funding rounds 3

Series A · $52.5M

Biorce closed a $52.5M Series A (reported locally as roughly €43.8-44.3M) for its Aika AI platform that designs and runs clinical trials, de…

2026-02-02

Seed · €5M

Barcelona-based Biorce raised €5M from Norrsken VC to expand its AI-native clinical-trial platform into the US and grow its engineering and …

2025-07-08

Seed · €3.5M

TechBio startup Biorce raised €3.5M co-led by YZR Capital and Mustard Seed Maze, with Outsized Ventures, Pathena and Plug and Play Tech Cent…

2024-11-14

News & media 9

Published	Article
2026-09-10	Spain's top-funded tech companies in H1 2026 ↗ Tech.eu
2026-08-10	10 European compliance startups to watch as AI Act enforcement kicks in ↗ EU-Startups
2026-03-25	Meet Biorce: The Health Tech Startup Transforming Clinical Trials and Winner of the 4YFN26 Awards ↗ 4YFN
2026-02-26	Pedro Coelho, Biorce: From Personal Loss to a $52M Series A and the One-Click Clinical Trial Vision ↗ EU.VC
2026-02-02	Biorce cierra una ronda Serie A de 52,5 millones de dólares para acelerar su expansión internacional ↗ El Referente
2026-02-02	How Barcelona's Biorce plans to use $52M to set a new global standard for clinical trials ↗ Tech Funding News
2026-02-02	Barcelona-based Biorce closes €43.8 million Series A to accelerate AI-driven clinical trials ↗ EU-Startups
2025-07-08	Barcelona's Biorce raises €5M: CEO Pedro Coelho on tackling clinical trial delays with AI, US expansion, and hiring plans ↗ Silicon Canals
2024-11-14	Barcelona-based Biorce secures €3.5 million aiming to transform clinical trials through AI ↗ EU-Startups